SFEBES2020

17:50

Session starts at 17:50
PL3
TBC
Dame Frances Ashcroft (University of Oxford Medical Sciences Division, UK)

14:30

Session starts at 14:30
PL2
TBC
Dr Davide Calebiro (Birmingham, UK)

10:30

Session starts at 10:30
WIN1
What Is New (Basic)
TBC

11:05

Session starts at 11:05
HDI1.2
How do I investigate a young person with a low trauma fracture?
TBC

11:05

Session starts at 11:05
HDI1.3
How do I use AMH in clinical practice?
TBC

11:05

Session starts at 11:05
HDI1.5
How do I keep my patients with adrenal insufficiency safe?
TBC

11:35

Session starts at 11:05
CMW1.2
TBC
TBC

12:05

Session starts at 11:05
CMW1.3
TBC
TBC

11:35

Session starts at 11:05
BPW1.2
TBC
TBC

12:05

Session starts at 11:05
BPW1.3
What You Need to Know About Immunometabolism
TBC

18:20

Session starts at 18:20
D1.1
Is Pre-Operative Blockade Necessary in Catecholamine Producing Tumours?
TBC

08:30

Session starts at 08:30
PL4
TBC
Dr Daniel Drucker (University of Toronto Lunenfeld-Tanenbaum Research Institute, Canada)

18:20

Session starts at 18:20
PL6
TBC
Professor Nelly Pitteloud (Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne,Switzerland)

17:45

Session starts at 16:45
SE1.3
TBC
Professor Richard Ivell (University of Nottingham, UK)

09:35

Session starts at 09:35
EC1.1
Early Career Lecture Basic
TBC

09:55

Session starts at 09:35
EC1.2
Early Career Lecture Clinical
TBC

10:15

Session starts at 09:35
EC1.3
CET Best Abstract Clinical
TBC

10:25

Session starts at 09:35
EC1.4
CET Best Abstract Basic
TBC

11:05

Session starts at 11:05
S1.1
TBC
TBC

11:35

Session starts at 11:05
S1.2
TBC
TBC

11:05

Session starts at 11:05
S2.1
TBC
TBC

12:05

Session starts at 11:05
S2.3
TBC
TBC

11:05

Session starts at 11:05
S3.1
Investigating Immune Micro-environments To Better Inform the Utility of Immune Check Point Inhibitors in Neoplasia
TBC

12:05

Session starts at 11:05
S3.3
TBC
TBC

16:45

Session starts at 16:45
HDI2.1
How Do I Investigate Low Alkaline Phosphatase?
TBC

17:00

Session starts at 16:45
HDI2.2
How Do I Manage End Secretory Endocrine Cancer at the End of Life?
TBC

17:30

Session starts at 16:45
HDI2.4
How Do I Screen for Cardiovascular Effects of Cancer Treatments?
TBC

17:45

Session starts at 16:45
HDI2.5
TBC
TBC

17:15

Session starts at 16:45
BPW2.2
Thyroid Regeneration Using iPSC
TBC

17:30

Session starts at 17:30
PL10
TBC
Dr Anne White (University of Manchester, UK)

16:50

Session starts at 16:50
PL9
TBC
Professor David Ray (Oxford University, UK)

08:30

Session starts at 08:30
PL7
TBC
Professor Fredrik Karpe (University of Oxford, UK)

10:50

Session starts at 10:50
S4.1
TBC
TBC

11:20

Session starts at 10:50
S4.2
TBC
TBC

11:50

Session starts at 10:50
S5.3
TBC
TBC

11:50

Session starts at 10:50
S6.3
TBC
TBC

12:25

Session starts at 12:25
MTE4
Probe or Palpate? What is the Optimum Long Term Thyroid Surveillance in Cancer Survivors?
TBC

12:25

Session starts at 12:25
MTE6
TBC
TBC

16:15

Session starts at 15:15
CMW2.3
TBC
TBC

15:15

Session starts at 15:15
TBC
TBC

15:37

Session starts at 15:15
TBC
TBC

15:15

Session starts at 15:15
TBC
TBC

16:15

Session starts at 15:15
TBC
TBC

16 November 2020
12:35 - 13:55 
Oral Posters 1 - Thyroid
Chair: TBC
16 November 2020
12:35 - 13:55 
Oral Posters 2 - Adrenal and Cardiovascular
Chair: TBC
16 November 2020
15:05 - 16:35 
Oral Communications 1 - Reproductive Endocrinology
Chair: TBC
16 November 2020
15:05 - 16:35 
Oral Communications 2 - Neoplasia and Late Effects
Chair: TBC
16 November 2020
15:05 - 16:35 
Oral Communications 3 - Metabolism and Obesity
Chair: TBC
18 November 2020
15:15 - 16:45 
Early Careers Session
Chair: TBC
15:15

Session starts at 15:15
TBC
TBC

15:37

Session starts at 15:15
TBC
TBC

15:48

Session starts at 15:15
Research Facilitation or Management
Dr Tim Giles (Birmingham, UK)

15:59

Session starts at 15:15
NHS Leadership and Policy
Professor Neil Gittoes (University of Birmingham, UK)

16:10

Session starts at 15:15
NHS Leadership and Policy
Dr Kristien Boelaert (University of Birmingham, UK)

16:21

Session starts at 15:15
Clinical Teaching Careers
Professor Maralyn Druce (Queen Mary University of London, UK)